Investigational Drug Information for Funapide
✉ Email this page to a colleague
What is the development status for investigational drug Funapide?
Funapide is an investigational drug.
There have been 3 clinical trials for Funapide.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 26th 2015.
The most common disease conditions in clinical trials are Osteoarthritis, Knee, Osteoarthritis, and Pain, Postoperative. The leading clinical trial sponsors are Teva Branded Pharmaceutical Products R&D, Inc., Teva Branded Pharmaceutical Products, R&D Inc., and Lotus Clinical Research, LLC.
Summary for Funapide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 46 |
| WIPO Patent Applications | 28 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 2 (2015-02-26) |
| Vendors | 0 |
Recent Clinical Trials for Funapide
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy | Lotus Clinical Research, LLC | Phase 1 |
| Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy | Flexion Therapeutics, Inc. | Phase 1 |
| A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN) | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 2 |
Clinical Trial Summary for Funapide
Top disease conditions for Funapide
Top clinical trial sponsors for Funapide
US Patents for Funapide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
